The Registry of Toxic Effects of Chemical Substances
Silica, crystalline - quartz |
UPDATE: May 2005 | MW: 60.09 | MF: O2Si |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA damage
|
intratracheal | rat
3 mg/kg
|
TXAPA9 189,84,2003
|
micronucleus test
|
hamster
lung
|
160 µg/cm2
|
MUREAV 335,27,1995
|
micronucleus test
|
human
lung
|
40 µg/cm2
|
MUREAV 335,27,1995
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 50 mg/m3/6 hour/71 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
ENVRAL 40,499,1986
|
implant | mouse
lowest published toxic dose: 4,000 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Kidney, Ureter, and Bladder: Bladder tumors
BJCAAI 22,825,1968
|
implant | rat
lowest published toxic dose: 900 mg/kg
|
Tumorigenic: Neoplastic by RTECS criteria | Gastrointestinal: Tumors Tumorigenic: Tumors at site of application
AICCA6 10,119,1954
|
implant | rat
toxic dose : 4,554 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Tumorigenic: Tumors at site of application
CORTBR 88,223,1972
|
intrapleural | hamster
lowest published toxic dose: 83 mg/kg
|
Tumorigenic: Neoplastic by RTECS criteria | Tumorigenic: Tumors at site of application
31BYAP -,92,1974
|
intrapleural | rat
lowest published toxic dose: 90 mg/kg
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease
JNCIAM 57,509,1976
|
intrapleural | rat
toxic dose : 200 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Bronchogenic carcinoma
JNCIAM 48,797,1972
|
intrapleural | rat
toxic dose : 100 mg/kg
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Lung, Thorax, or Respiration: Tumors
BJCAAI 41,908,1980
|
intrapleural | rat
toxic dose : 100 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) Lung, Thorax, or Respiration: Tumors
AIHAAP 41,836,1980
|
intrapleural | rat
toxic dose : 100 mg/kg
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
JJIND8 79,797,1987
|
intraperitoneal | rat
lowest published toxic dose: 45 mg/kg
|
Tumorigenic: Carcinogenic by RTECS criteria | Tumorigenic: Tumors at site of application
ZHPMAT 162,467,1976
|
intraperitoneal | rat
toxic dose : 90 mg/kg/4 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Blood: Lymphoma including Hodgkin's disease
JNCIAM 57,509,1976
|
intraperitoneal | rat
toxic dose : 450 mg/kg/4 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Gastrointestinal: Tumors
NATWAY 59,318,1972
|
intratracheal | rat
lowest published toxic dose: 111 mg/kg
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
CREMEX 2,243,1986
|
intratracheal | rat
lowest published toxic dose: 100 mg/kg/19 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors
EVHPAZ 34,47,1980
|
intravenous | rat
lowest published toxic dose: 90 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Blood: Lymphoma including Hodgkin's disease
JNCIAM 57,509,1976
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | human
lowest published toxic concentration: 16 million particles per cubic foot/8 hour/17.9 year- intermittent
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | Lung, Thorax, or Respiration: Cough Lung, Thorax, or Respiration: Dyspnea
NTIS** PB246-697
|
inhalation | human
lowest published lethal concentration: 300 µg/m3/10 year- intermittent
|
Liver: Other changes
|
ANYAA9 271,324,1976
|
inhalation | mouse
lowest published toxic concentration: 40 mg/kg
|
Lung, Thorax, or Respiration: Other changes
|
TOXID9 72,45,2003
|
inhalation | mouse
lowest published toxic concentration: 40 mg/kg
|
Immunological Including Allergic: Decrease in cellular immune response
|
TOXID9 72(Suppl 1),372,2003
|
inhalation | rat
lowest published toxic concentration: 200 mg/kg
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | Lung, Thorax, or Respiration: Other changes Nutritional and Gross Metabolic: Changes in: Fe
AJPHAP 267,L686,1994
|
implant | rabbit
lowest published toxic dose: 20 mg/kg
|
Lung, Thorax, or Respiration: Fibrosing alveolitis | Immunological Including Allergic: Increase in cellular immune response Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXAPA9 183,46,2002
|
intratracheal | mouse
lethal dose : >20 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
ARDSBL 141(Suppl),A3-A937,1990
|
intratracheal | mouse
lowest published toxic dose: 16.7 mg/kg
|
Lung, Thorax, or Respiration: Acute pulmonary edema
|
TOXID9 72,44,2003
|
intratracheal | mouse
lowest published toxic dose: 80 mg/kg
|
Lung, Thorax, or Respiration: Fibrosis (interstitial) | Immunological Including Allergic: Increase in cellular immune response Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXAPA9 185,1,2002
|
intratracheal | mouse
lowest published toxic dose: 80 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOXID9 72(Suppl 1),353,2003
|
intratracheal | mouse
lowest published toxic dose: 100 mg/kg
|
Tumorigenic: Increased incidence of tumors in susceptible strains
|
TOLED5 142,71,2003
|
intratracheal | rat
lowest published lethal dose: 200 mg/kg
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis)
|
BJIMAG 10,9,1953
|
intratracheal | rat
lowest published lethal dose: 250 mg/kg
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | Lung, Thorax, or Respiration: Other changes
JTEHD6 19,403,1986
|
intratracheal | rat
lowest published toxic dose: 240 mg/kg/1 hour
|
Lung, Thorax, or Respiration: Other changes | Lung, Thorax, or Respiration: Changes in lung weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
IVIEM* -,453,1985
|
intratracheal | rat
lowest published toxic dose: 1.5 mg/kg
|
Lung, Thorax, or Respiration: Fibrosis (interstitial)
|
ARTODN 74,716,2001
|
intratracheal | rat
lowest published toxic dose: 15.69 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOXID9 72,43,2003
|
intratracheal | rat
lowest published toxic dose: 25 mg/kg
|
Lung, Thorax, or Respiration: Cough | Lung, Thorax, or Respiration: Other changes Lung, Thorax, or Respiration: Other changes
TOXID9 72,45,2003
|
intratracheal | rat
lowest published toxic dose: 150 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
TOXID9 72(Suppl 1),372,2003
|
intravenous | dog
lowest published lethal dose: 20 mg/kg
|
N/R
|
BIJOAK 27,1007,1933
|
intravenous | mouse
lowest published lethal dose: 40 mg/kg
|
N/R
|
JNCIAM 1,241,1940
|
intravenous | rat
lowest published lethal dose: 90 mg/kg
|
N/R
|
JNCIAM 57,509,1976
|
oral | rat
lowest published toxic dose: 120 gm/kg
|
Gastrointestinal: Hypermotility, diarrhea | Gastrointestinal: Other changes
EPASR* #86940001000,1994
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | domestic animal
lowest published toxic concentration: 1,000 gm/m3/10 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
EXLRDA 15,409,1989
|
inhalation | guinea pig
lowest published toxic concentration: 28 mg/m3/3 week- intermittent
|
Lung, Thorax, or Respiration: Other changes | Lung, Thorax, or Respiration: Changes in lung weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TXAPA9 68,152,1983
|
inhalation | hamster
lowest published toxic concentration: 3 mg/m3/6 hour/78 week- intermittent
|
Lung, Thorax, or Respiration: Fibrosis (interstitial) | Lung, Thorax, or Respiration: Changes in lung weight
INHTE5 10,699,1998
|
inhalation | monkey
lowest published toxic concentration: 10 mg/m3/818 day- intermittent
|
Lung, Thorax, or Respiration: Other changes
|
TOXID9 72,44,2003
|
inhalation | mouse
lowest published toxic concentration: 1,475 µg/m3/8 hour/21 week- intermittent
|
Lung, Thorax, or Respiration: Other changes
|
ENVRAL 39,331,1986
|
inhalation | mouse
lowest published toxic concentration: 4,932 µg/m3/24 hour/39 week- continuous
|
Endocrine: Changes in spleen weight | Immunological Including Allergic: Decrease in humoral immune response
ENVRAL 21,298,1980
|
inhalation | rat
lowest published toxic concentration: 80 mg/m3/26 week- intermittent
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | Blood: Changes in spleen Immunological Including Allergic: Decrease in cellular immune response
GTPZAB 31(1),24,1987
|
inhalation | rat
lowest published toxic concentration: 108 mg/m3/6 hour/3 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases Biochemical: Metabolism (intermediary): Other proteins
TXAPA9 107,350,1991
|
inhalation | rat
lowest published toxic concentration: 58 mg/m3/13 week- intermittent
|
Lung, Thorax, or Respiration: Other changes | Endocrine: Changes in thymus weight Blood: Changes in leukocyte (WBC) count
FCTOD7 29,341,1991
|
inhalation | rat
lowest published toxic concentration: 15 mg/m3/26 week- intermittent
|
Lung, Thorax, or Respiration: Other changes
|
TOXID9 72,44,2003
|
inhalation | rat
lowest published toxic concentration: 0.74 mg/m3/2 year- intermittent
|
Lung, Thorax, or Respiration: Other changes
|
TOXID9 72,44,2003
|
inhalation | rat
lowest published toxic concentration: 10 mg/m3/75 day- intermittent
|
Lung, Thorax, or Respiration: Other changes
|
TOXID9 72,44,2003
|
intratracheal | rat
lowest published toxic dose: 2.88 mg/kg/12 week- intermittent
|
Blood: Other changes | Blood: Changes in leukocyte (WBC) count
TXCYAC 175,63,2002
|
intratracheal | rat
lowest published toxic dose: 11.52 mg/kg/12 week- intermittent
|
Lung, Thorax, or Respiration: Other changes | Blood: Other changes Blood: Changes in leukocyte (WBC) count
TXCYAC 175,63,2002
|
intratracheal | rat
lowest published toxic dose: 240 µg/kg/12 week- intermittent
|
Lung, Thorax, or Respiration: Sputum | Immunological Including Allergic: Decrease in cellular immune response
TXCYAC 175,63,2002
|
intratracheal | rat
lowest published toxic dose: 960 µg/kg/12 week- intermittent
|
Lung, Thorax, or Respiration: Sputum | Immunological Including Allergic: Decrease in cellular immune response Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 175,63,2002
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.05 mg/m3 (R)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Suspected Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 42,39,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 68,41,1997
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMEMDT 42,39,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Sufficient Evidence
|
IMEMDT 68,41,1997
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 1
|
IMEMDT 68,41,1997
|
TOXICOLOGY REVIEW
|
|
31BYAP -,94,1974
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,83,2002
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,223,2003
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - respirable dust in air
|
time-weighted average 10 mg/m3/% resp. SiO2+2
|
DTLWS* 3,33,1973
|
Mine Safety and Health Administration (MSHA) STANDARD - total dust in air
|
time-weighted average 30 mg/m3/2(SiO2+3)
|
DTLWS* 3,33,1973
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 10 mg/m3/(% resp SiO2+2)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 10 mg/m3/(% resp SiO2+2)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 30 mg/m3/(%SiO2+2), total dust
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 250 million particles per cubic foot/(%SiO2+5)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 250 million particles per cubic foot/(%SiO2+5)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRIA
|
MAK 0.15 mg/m3, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.1 mg/m3, JAN1993
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.2 mg/m3, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 10/(X+2), JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 0.15 mg/m3, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.1 mg/m3 (resp. dust), JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.3 mg/m3 (total dust), JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.075 mg/m3, 2003
|
Occupational Exposure Limit - SWEDEN
|
NGV 0.1 mg/m3 (resp. dust), JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.15 mg/m3, JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 10 mg/m3 (resp. dust), JAN1993
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 30 mg/m3 (total dust), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.3 mg/m3, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Suspected Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Suspected Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO SILICA, crystalline quartz-air
|
Carcinogen; | 10 hour time-weighted average 0.05 mg/m3
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 66495; | Number of Industries 59; Total Number of Facilities 4,077; Number of Occupations 82; Total Number of Employees Exposed 81,221
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X6478; | Number of Industries 2; Total Number of Facilities 135; Number of Occupations 10; Total Number of Employees Exposed 8,927; Total Number of Female Employees Exposed 741
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 66495; |
Number of Industries 254; Total Number of Facilities 53,724; Number of Occupations 173; Total Number of Employees Exposed 944,731; Total Number of Female Employees Exposed 112,888 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a mineral, natural or synthetic fiber
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 36, 1981
|
NIOSH Analytical Method, 1994: Silica, crystalline in coal mine dust, by IR, 7603
|
NIOSH Analytical Method, 1994: Silica, crystalline, by XRD, 7500; by VIS, 7600; by IR, 7602
|
NTP 11th Report on Carcinogens,2004:Known to be human carcinogen
|
OSHA ANALYTICAL METHOD #ID142
|
OSHA ANALYTICAL METHOD #ID-125G
|
|
REFERENCES:
CODEN
|
|
REFERENCE
31BYAP
|
"Experimental Lung Cancer: Carcinogenesis and Bioassays, International Symposium, 1974,"
Karbe, E., and J.F. Park, eds., Springer-Verlag New York, Inc., 1974
|
AICCA6
|
Acta Unio Internationalis Contra Cancrum. (Louvain, Belgium) V.1-20, 1936-64. For publisher
information, see IJCNAW.
|
AIHAAP
|
American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH
44311) V.19- 1958-
|
AJPHAP
|
American Journal of Physiology. (American Physiological Soc., 9650 Rockville Pike, Bethesda,
MD 20814) V.1- 1898-
|
ANYAA9
|
Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New
York, NY 10021) V.1- 1877-
|
ARDSBL
|
American Review of Respiratory Disease. (American Lung Assoc., 1740 Broadway, New York, NY
10019) V.80- 1959-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
BIJOAK
|
Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex
CO2 8HP, UK) V.1- 1906-
|
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
BJIMAG
|
British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME
04046) V.1- 1944-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CORTBR
|
Clinical Orthopaedics and Related Research. (Lippincott/Harper, Journal Fulfillment Dept.,
2350 Virginia Ave., Hagerstown, MD 21740) No.26- 1963-
|
CREMEX
|
Cancer Research Monographs. (Praeger Pub., 521 Fifth Ave., New York, NY 10175) V.1- 1983-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
DTLWS*
|
"Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For
publisher information, see 85INA8.
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
EPASR*
|
United States Environmental Protection Agency, Office of Pesticides and Toxic Substances.
(U.S. Environmental Protection Agency, 401 M St., SW, Washington, DC 20460) History unknown.
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
EXLRDA
|
Experimental Lung Research. (Hemisphere Publishing, c/o Taylor & Francis 1900 Frost Road,
Suite 101, Bristol, PA 19007) V.1- 1980-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INHTE5
|
Inhalation Toxicology. (Published by Taylor & Francis Health, 11 New Fetter Lane, London EC4P
4EE) V.1- 1989-
|
IVIEM*
|
In Vitro Effects of Mineral Dusts (Third International Workshop, E. G. Beck, J. Bignon,
Editors; Berlin, Springer-Verlag) 1985.
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JNCIAM
|
Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher
information, see JJIND8.
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NATWAY
|
Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.1- 1913-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
ZHPMAT
|
Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung
1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin.
(Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC.
|
|